Elie Dolgin, PHD, Science Journalist
Nature Outlook logo

Nature Outlook

A participant holds his hand in a bucket of ice while Yingzi Lin monitors his pain response.
By Elie Dolgin September 25, 2024
Pain is defined subjectively, but an objective measure of the experience promises to transform its management.
Craig Ramirez and Andrew Hauser drinking beers in a pub.
By Elie Dolgin July 11, 2024
Joining a drug candidate to a protein that malignant cells naturally take up allowed one firm to come up with a potent anti-cancer therapy.
People being evacuated following flooding caused by the destruction of the Kakhovka dam in Ukraine.
By Elie Dolgin December 14, 2023
Climate change could intensify the role of this vital and strategic asset in armed conflict.
Oliver DeLong and his mother, Hillary DeLong
By Elie Dolgin September 27, 2023
Drugs that counter RSV infection can safeguard newborns, offering another mode of protection alongside vaccines.
Nicholas Vitanza (left) treated Emily Hood (right) using CAR-T-cell therapy
By Elie Dolgin December 19, 2022
The immunotherapy is beginning to show promise in solid tumours, but researchers want more dedicated research in young people.
Scanning electron micrograph of human brain cells — can psychedelics rewire them safely?
By Elie Dolgin September 28, 2022
Drugs under development offer the mental-health benefits of psilocybin and similar substances without inducing strong hallucinatory effects.
Illustration of pill bottle being squeezed.
By Elie Dolgin March 30, 2022
Finite courses of treatment could get the virus under control — with the right combination of drugs.
Illustration of cell garbage disposal
By Elie Dolgin January 19, 2022
Could targeting autophagy — often likened to a cellular trash management system — extend life? Some researchers are unconvinced.
Tea cups in a line
By Elie Dolgin February 6, 2019
Genetic manipulation and innovative breeding techniques are paving the way to new tea varieties.
Lab-grown meat with cheese stacked 2 layers high
By Elie Dolgin February 6, 2019
'Clean meat’ firms have drawn tens of millions of dollars in investment in recent years, but technical hurdles remain.
Show More
Share by: